Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix Statistics

Total Valuation

OCUL has a market cap or net worth of $1.18 billion. The enterprise value is $903.77 million.

Market Cap	1.18B
Enterprise Value	903.77M

Important Dates

The last earnings date was Monday, May 5, 2025, before market open.

Earnings Date	May 5, 2025
Ex-Dividend Date	n/a

Share Statistics

OCUL has 159.30 million shares outstanding. The number of shares has increased by 79.29% in one year.

Current Share Class	159.30M
Shares Outstanding	159.30M
Shares Change (YoY)	+79.29%
Shares Change (QoQ)	+0.82%
Owned by Insiders (%)	0.87%
Owned by Institutions (%)	63.75%
Float	124.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.77
Forward PS	16.65
PB Ratio	4.43
P/TBV Ratio	4.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	15.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.22, with a Debt / Equity ratio of 0.29.

Current Ratio	10.22
Quick Ratio	9.89
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.44

Financial Efficiency

Return on equity (ROE) is -57.19% and return on invested capital (ROIC) is -31.18%.

Return on Equity (ROE)	-57.19%
Return on Assets (ROA)	-27.21%
Return on Invested Capital (ROIC)	-31.18%
Return on Capital Employed (ROCE)	-55.89%
Revenue Per Employee	$217,690
Profits Per Employee	-$703,325
Employee Count	274
Asset Turnover	0.13
Inventory Turnover	53.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.48% in the last 52 weeks. The beta is 1.50, so OCUL's price volatility has been higher than the market average.

Beta (5Y)	1.50
52-Week Price Change	+30.48%
50-Day Moving Average	7.45
200-Day Moving Average	8.50
Relative Strength Index (RSI)	48.11
Average Volume (20 Days)	1,577,076

Short Selling Information

The latest short interest is 12.98 million, so 8.15% of the outstanding shares have been sold short.

Short Interest	12.98M
Short Previous Month	14.10M
Short % of Shares Out	8.15%
Short % of Float	10.44%
Short Ratio (days to cover)	7.69

Income Statement

In the last 12 months, OCUL had revenue of $59.65 million and -$192.71 million in losses. Loss per share was -$1.15.

Revenue	59.65M
Gross Profit	-95.67M
Operating Income	-205.68M
Pretax Income	-138.36M
Net Income	-192.71M
EBITDA	-201.83M
EBIT	-205.68M
Loss Per Share	-$1.15

Balance Sheet

The company has $349.68 million in cash and $76.22 million in debt, giving a net cash position of $273.46 million or $1.72 per share.

Cash & Cash Equivalents	349.68M
Total Debt	76.22M
Net Cash	273.46M
Net Cash Per Share	$1.72
Equity (Book Value)	265.93M
Book Value Per Share	1.67
Working Capital	349.77M

Cash Flow

In the last 12 months, operating cash flow was -$145.46 million and capital expenditures -$2.97 million, giving a free cash flow of -$148.43 million.

Operating Cash Flow	-145.46M
Capital Expenditures	-2.97M
Free Cash Flow	-148.43M
FCF Per Share	-$0.93

Margins

Gross Margin	-160.40%
Operating Margin	-344.83%
Pretax Margin	-323.09%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OCUL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-79.29%
Shareholder Yield	-79.29%
Earnings Yield	-16.37%
FCF Yield	-12.61%

Analyst Forecast

The average price target for OCUL is $16.11, which is 118.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.11
Price Target Difference	118.15%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	61.42%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OCUL has an Altman Z-Score of 1.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.54
Piotroski F-Score	1